Invention Grant
- Patent Title: EPHA2 receptor antagonist antibodies
- Patent Title (中): EPHA2受体拮抗剂抗体
-
Application No.: US12373574Application Date: 2007-07-13
-
Publication No.: US08460667B2Publication Date: 2013-06-11
- Inventor: Veronique Blanc , Claudia Fromond , Fabienne Parker , Jiawen Han , Daniel Tavares , Chonghui Zhang , Min Li , Xiao-Mai Zhou , Michel Streuli
- Applicant: Veronique Blanc , Claudia Fromond , Fabienne Parker , Jiawen Han , Daniel Tavares , Chonghui Zhang , Min Li , Xiao-Mai Zhou , Michel Streuli
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agent J. Darrell Fontenot
- Priority: EP06291160 20060718
- International Application: PCT/IB2007/003074 WO 20070713
- International Announcement: WO2008/010101 WO 20080124
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C07K16/28
Abstract:
Antagonistic antibodies that specifically bind to and inhibit Class A Eph receptors are provided. Also provided are cytotoxic conjugates, pharmaceutical compositions and kits comprising these antibodies.
Public/Granted literature
- US20100047257A1 ANTAGONIST ANTIBODY FOR THE TREATMENT OF CANCER Public/Granted day:2010-02-25
Information query
